Livingstone Health Holdings Limited (SGX:PRH)
Singapore · Delayed Price · Currency is SGD 0.0250
0.00 (0.00%)
At close: Aug 28, 2026
SGX:PRH Ratios and Metrics
Market cap in millions SGD. Fiscal year is April - March.
Millions SGD. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 27, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Market Capitalization | 16 | 16 | 14 | 10 | 22 | 46 |
Market Cap Growth | 14.00% | 11.36% | 43.60% | -55.79% | -51.87% | -21.74% |
Enterprise Value | 15 | 15 | 17 | 15 | 27 | 52 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 27, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 70.70 | 70.57 | 25.39 | - | 30.80 | 15.29 |
PS Ratio | 0.54 | 0.54 | 0.51 | 0.39 | 0.68 | 1.35 |
PB Ratio | 3.49 | 3.48 | 2.88 | 2.12 | 3.52 | 8.13 |
P/TBV Ratio | 11.89 | 11.87 | 6.29 | 89.78 | 14.27 | 33.98 |
P/FCF Ratio | 5.56 | 5.55 | 3.51 | 22.25 | 10.55 | 12.61 |
P/OCF Ratio | 4.98 | 4.97 | 3.28 | 11.40 | 7.20 | 9.94 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 27, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 0.52 | 0.53 | 0.61 | 0.59 | 0.83 | 1.51 |
EV/EBITDA Ratio | 7.34 | 7.15 | 6.22 | 156.75 | 7.77 | 9.35 |
EV/EBIT Ratio | - | - | 90.92 | - | 17.13 | 12.98 |
EV/FCF Ratio | 5.39 | 5.44 | 4.19 | 33.77 | 12.98 | 14.05 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 27, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 1.10 | 1.10 | 1.13 | 1.95 | 1.25 | 1.30 |
Debt / EBITDA Ratio | 2.32 | 2.32 | 2.05 | 95.19 | 2.24 | 1.34 |
Debt / FCF Ratio | 1.76 | 1.76 | 1.38 | 20.51 | 3.75 | 2.01 |
Net Debt / Equity Ratio | 0.41 | 0.41 | 0.39 | 1.21 | 0.58 | 0.27 |
Net Debt / EBITDA Ratio | 0.87 | 0.87 | 0.70 | 58.88 | 1.05 | 0.28 |
Net Debt / FCF Ratio | 0.66 | 0.66 | 0.47 | 12.68 | 1.75 | 0.42 |
Asset Turnover | 1.51 | 1.51 | 1.33 | 1.14 | 1.50 | 1.65 |
Inventory Turnover | 25.54 | 25.54 | 24.48 | 26.75 | 35.84 | 41.51 |
Quick Ratio | 0.77 | 0.77 | 0.83 | 1.07 | 1.00 | 1.18 |
Current Ratio | 1.03 | 1.03 | 1.02 | 1.15 | 1.06 | 1.33 |
Return on Equity (ROE) | -10.53% | -10.53% | 3.49% | -52.91% | 21.39% | 93.37% |
Return on Assets (ROA) | -0.84% | -0.84% | 0.56% | -6.04% | 4.55% | 12.00% |
Return on Invested Capital (ROIC) | -4.08% | -3.95% | 2.17% | -21.23% | 13.26% | 58.77% |
Return on Capital Employed (ROCE) | -2.70% | -2.70% | 1.90% | -18.40% | 15.20% | 35.90% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 27, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 1.41% | 1.42% | 3.94% | -29.19% | 3.25% | 6.54% |
FCF Yield | 17.97% | 18.01% | 28.48% | 4.49% | 9.47% | 7.93% |
Payout Ratio | - | - | - | - | 72.46% | - |
Buyback Yield / Dilution | -6.15% | -6.15% | -51.65% | -1.32% | -36.85% | -0.93% |